Guest Editor(s)

• Dr. Jun Zhang, PhD

  Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine; Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA.

  Website | E-mail

Special Issue Introduction

This special issue aims to bring readers the up-to-date view of advancements in the scientific and technology innovations, translational and basic-science studies, and clinical trials of cerebral cavernous malformations (CCMs), a microvascular disorder in the central nervous system. This special issue plans to cover the most innovative technologies and scientific findings on this challenging neurovascular condition. Manuscripts range from original articles, case reports, commentaries, to expert reviews in the latest clinical and translational research on the health disparity, prevention, treatment, prognosis and diagnosis, and basic research in epidemiological, genetic, molecular, cellular mechanisms and pathophysiology of CCMs. Our focus also includes molecular and cell biology, systems biology in CCM signaling complex, protein structure and functions of CCM proteins. Furthermore, proposal for new drug and/or clinical trial, proof of concepts or new hypotheses in CCM research are also welcome.

Keywords

Cerebral cavernous malformations, prevention, treatment, prognosis and diagnosis, epidemiological, genetic, molecular, cellular mechanisms, pathophysiology

Submission Deadline

15 Feb 2021

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://vpjournal.net/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/VP/?IssueId=459
Submission Deadline: 15 Feb 2021
Contacts: Mavis Wei, Managing Editor, mavis@vpjournal.net